PrognomiQ

About PrognomiQ

PrognomiQ is focused on transforming early disease detection and treatment, particularly for cancer and other complex diseases, by harnessing the power of multi-omics data. Their mission is to develop innovative test products that enable early detection and improve treatment outcomes through proprietary proteomic, genomic, and metabolomic data insights.

Products & Services

Transformative Test Products:PrognomiQ is developing test products for early disease detection and treatment, leveraging proprietary proteomic data combined with genomic and metabolomic information to create innovative healthcare solutions.

Multi-Omics Platform:A proprietary platform designed to generate high-quality proteomic, genomic, and metabolomic data at scale, driving the development of transformative healthcare products for early disease detection.

Specialties

Proteomics Multi-Omics Data Analysis Early Disease Detection Cancer and Complex Disease Treatment Genomics Metabolomics

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series D T: - FT: Series D	A: 34000000 MR: - FA: 34 million FAN: 34000000	D: 2024-11-05 FD: 2024-11-05	6 investors

Series D Latest

2024-11-05

$34.0M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

P

Philip Ma

Chief Executive Officer

J

Joel Kaufman

Chief Financial Officer

B

Brian Koh

Chief Medical Officer

B

Bruce Wilcox

Chief Technology Officer

K

Katherine Dalao

VP, Quality Assurance and Clinical Lab Affairs

M

Manway Liu

VP, Data Sciences

View 26 more team members with Pro

Unlock Full Team Directory

Recent News

PrognomiQ Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised